Intravenous Pyelogram (IVP)

 

What is an intravenous pyelogram (IVP)?

An intravenous pyelogram, also called intravenous urography, is a diagnostic x-ray of the kidneys, ureters, and bladder. When a contrast agent is injected intravenously (IV), the urinary tract will show up very clearly, which is not seen on regular x-rays. An intravenous pyelogram may be done for many reasons, including the following:

  • to detect kidney tumors
  • to identify blockages or obstructions of the normal flow of urine
  • to detect kidney or bladder stones
  • to establish if the prostate gland is enlarged
  • to detect injuries to the urinary tract

As the contrast dye moves into and through the kidneys, ureters, and bladder, x-rays taken at short intervals can capture its movement. A delay in the contrast dye moving through the urinary system may indicate an obstruction (blockage) in the kidney's blood flow or poor kidney function.

A radiologist can then assess the function and detect abnormalities of the urinary system. This test is usually ordered as one of the first tests in cases of suspected kidney disease or urinary tract disorders.

What is an x-ray? 

X-rays use invisible electromagnetic energy beams to produce images of internal tissues, bones, and organs on film. X-rays are made by using external radiation to produce images of the body, its organs, and other internal structures for diagnostic purposes. X-rays pass through body structures onto specially-treated plates (similar to camera film) and a "negative" type picture is made (the more solid a structure is, the whiter it appears on the film).

IVP may be performed at the same time as a computed tomography (CT) scan of the kidneys (also called nephrotomography). This test, like the IVP, is performed after contrast dye has been injected, but unlike a standard x-ray, provides images of layers or "slices" of the kidney.
As newer technologies are developed, other procedures such as CT and ultrasonography (high-frequency sound waves) are often used instead of IVP.

Picture of an intravenous pyelogram film

How are intravenous pyelograms performed?

Intravenous pyelograms are usually performed on an outpatient basis, although they can be part of inpatient care. The patient may be asked to take a laxative to cleanse the bowel before the examination. The procedure may be performed with minimal risk to the patient.

Although each facility may have specific protocols in place, generally, an intravenous pyelogram procedure follows this process:

  1. The patient will be positioned on the x-ray table.
  2. A preliminary x-ray will be taken.
  3. An intravenous (IV) line will be started in the hand or arm for injection of the contrast medication.
  4. The radiologist will inject the contrast agent into the vein in the arm.
  5. During the injection of the contrast agent, the patient may feel warm and become flushed, only for a minute or so. This reaction is normal.
  6. X-rays will be taken at intervals after the dye has been injected.
  7. At times the patient may have to change positions as the x-rays are taken.
  8. The patient will be asked to empty the bladder.
  9. A final x-ray will be taken after urination to determine the amount of contrast dye remaining in the urinary tract.
Latest Cancer News
Arimidex® Not Associated with Cognitive Impairment Among Postmenopausal Women at High Risk for Breast Cancer

October 10, 2008 — Researchers from the United Kingdom have reported that the use of the aromatase inhibitor Arimidex® (anastrozole) does not appear to be associated with cognitive impairment among postmenopausal women at a high risk of developing breast cancer. These results were recently published in the October, 2008 issue of Lancet Oncology.

United States Preventive Task Force Provides Recommendations for Colorectal Cancer Screening

October 10, 2008 — The United States Preventive Services Task Force (USPSTF) has recently issued recommendations for the screening of colorectal cancer. These recommendations were published in the Archives of Internal Medicine.

Nexavar® May Overcome Resistance to Arimidex® in Breast Cancer

October 10, 2008 — Researchers from Georgetown University have reported that the addition of Nexavar® (sorafenib) to Arimidex® (anastrozole) helps restore sensitivity to Arimidex among women with breast cancer. These results were recently presented at the 2008 annual American Society of Clinical Oncology (ASCO) breast cancer symposium.

Select news items provided by Reuters Health